Now showing items 1-5 of 5

    • Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial. 

      Mngadi, Kathryn Therese.; Maarschalk, Silvia.; Grobler, Anna Christina.; Mansoor, Leila Essop.; Fröhlich, Janet Ann.; Madlala, Bernadette T.; Ngcobo, Nelisiwe.; Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha. (Springer., 2014)
      Abstract available in pdf.
    • Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. 

      Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha.; Fröhlich, Janet Ann.; Grobler, Anna Christina.; Baxter, Cheryl.; Mansoor, Leila Essop.; Kharsany, Ayesha Bibi Mahomed.; Sibeko, Sengeziwe.; Mlisana, Koleka Patience.; Omar, Zaheen.; Gengiah, Tanuja Narayansamy.; Maarschalk, Silvia.; Arulappan, Natasha.; Mlotshwa, Mukelisiwe.; Morris, Lynn.; Taylor, Douglas. (American Association for the Advancement of Science., 2010)
      The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of tenofovir, a nucleotide reverse transcriptase inhibitor, for the ...
    • Mapping rural youth's experiences of school exclusion. 

      Maarschalk, Silvia. (2007)
      The South African context gives rise to a number of significant adversities that challenge the stability of the individual child and the survival of their families. The repercussions of these adversities are profound. Once ...
    • Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial. 

      Abdool Karim, Quarraisha.; Kharsany, Ayesha Bibi Mahomed.; Fröhlich, Janet Ann.; Baxter, Cheryl.; Yende Zuma, Nonhlanhla.; Mansoor, Leila Essop.; Mlisana, Koleka Patience.; Maarschalk, Silvia.; Arulappan, Natasha.; Grobler, Anna Christina.; Sibeko, Sengeziwe.; Omar, Zaheen.; Gengiah, Tanuja Narayansamy.; Mlotshwa, Mukelisiwe.; Samsunder, Natasha.; Abdool Karim, Salim Safurdeen. (Biomed Central, 2010)
      Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compared to men but have limited options to reduce their HIV risk. Microbicides could fill an important HIV prevention gap ...
    • Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial. 

      Sokal, David C.; Abdool Karim, Quarraisha.; Sibeko, Sengeziwe.; Yende Zuma, Nonhlanhla.; Mansoor, Leila Essop.; Baxter, Cheryl.; Grobler, Anna Christina.; Fröhlich, Janet Ann.; Kharsany, Ayesha Bibi Mahomed.; Miya, Nomsa.; Mlisana, Koleka Patience.; Maarschalk, Silvia.; Abdool Karim, Salim Safurdeen. (International Medical Press., 2012)
      Background: Tenofovir gel, used vaginally before and after coitus, reduced women’s acquisition of HIV by 39%. This is a safety assessment of tenofovir gel, including renal, bone, gastrointestinal, genital and haematological ...